Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis

被引:0
|
作者
Hardeep Singh Tuli
Jagjit Kaur
Kanupriya Vashishth
Katrin Sak
Ujjawal Sharma
Renuka Choudhary
Tapan Behl
Tejveer Singh
Sheetu Sharma
Adesh K. Saini
Kuldeep Dhama
Mehmet Varol
Gautam Sethi
机构
[1] Maharishi Markandeshwar Engineering College,Department of Biotechnology
[2] Maharishi Markandeshwar (Deemed to be University),Graduate School of Biomedical Engineering, Faculty of Engineering
[3] Mullana,Advance Cardiac Centre Department of Cardiology
[4] The University of New South Wales,Department of Pharmacology, School of Health Sciences & Technology (SoHST)
[5] PGIMER,Translanatal Oncology Laboratory, Department of Zoology
[6] NGO Praeventio,Department of Pharmacovigilace and Clinical Research
[7] University of Petroleum and Energy Studies,Division of Pathology
[8] Hansraj College,Department of Molecular Biology and Genetics, Faculty of Science
[9] Delhi University,Department of Pharmacology, Yong Loo Lin School of Medicine
[10] Chitkara University,Department of Human Genetics and Molecular Medicine, School of Health Sciences
[11] ICAR-Indian Veterinary Research Institute,undefined
[12] Mugla Sitki Kocman University,undefined
[13] National University of Singapore,undefined
[14] Central University of Punjab,undefined
来源
Archives of Toxicology | 2023年 / 97卷
关键词
ROS; Cancer; Angiogenesis; Metastasis; Inflammation; Apoptosis; miRNA;
D O I
暂无
中图分类号
学科分类号
摘要
ROS include hydroxyl radicals (HO.), superoxide (O2..), and hydrogen peroxide (H2O2). ROS are typically produced under physiological conditions and play crucial roles in living organisms. It is known that ROS, which are created spontaneously by cells through aerobic metabolism in mitochondria, can have either a beneficial or detrimental influence on biological systems. Moderate levels of ROS can cause oxidative damage to proteins, DNA and lipids, which can aid in the pathogenesis of many disorders, including cancer. However, excessive concentrations of ROS can initiate programmed cell death in cancer. Presently, a variety of chemotherapeutic drugs and herbal agents are being investigated to induce ROS-mediated cell death in cancer. Therefore, preserving ROS homeostasis is essential for ensuring normal cell development and survival. On account of a significant association of ROS levels at various concentrations with carcinogenesis in a number of malignancies, further studies are needed to determine the underlying molecular mechanisms and develop the possibilities for intervening in these processes.
引用
收藏
页码:103 / 120
页数:17
相关论文
共 50 条
  • [31] The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy
    Yan Wang
    Ziliang Wang
    Zihao Qi
    Sheng Yin
    Na Zhang
    Yang Liu
    Mingming Liu
    Jiao Meng
    Rongyu Zang
    Zhen Zhang
    Gong Yang
    Molecular Cancer, 13
  • [32] Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer
    Yang, Jingyun
    Hu, Xiaofei
    Wang, Yu
    Liu, Wenying
    Zhang, Mengjie
    Zhang, Anmei
    Ni, Bing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells (vol 24, pg 2452, 2020)
    Wang, H.
    Xu, T.
    Wu, L.
    Xu, H. -L.
    Liu, R. -M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (20) : 6159 - 6159
  • [34] Involvement of the uridine cytidine kinase 2 enzyme in cancer cell death: A molecular crosstalk between the enzyme and cellular apoptosis induction
    Malami, Ibrahim
    Abdul, Ahmad B.
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 1506 - 1510
  • [35] Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells
    Liu, JD
    Wang, YJ
    Chen, CH
    Yu, CF
    Chen, LC
    Lin, JK
    Liang, YC
    Lin, SY
    Ho, YS
    MOLECULAR CARCINOGENESIS, 2003, 37 (01) : 39 - 50
  • [36] Molecular Mechanisms of Celery Seed Extract Induced Apoptosis via S Phase Cell Cycle Arrest in the BGC-823 Human Stomach Cancer Cell Line
    Gao, Lin-Lin
    Feng, Lei
    Yao, Shu-Tong
    Jiao, Peng
    Qin, Shu-Cun
    Zhang, Wei
    Zhang, Ya-Bin
    Li, Fu-Rong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (10) : 2601 - 2606
  • [37] Up-regulation of reactive oxygen species (ROS) and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor
    Yoon, DY
    Cho, YS
    Park, JW
    Kim, SH
    Kim, JW
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (05) : 499 - 506
  • [38] S-Phase Cell Cycle Arrest, Apoptosis, and Molecular Mechanisms of Aplasia Ras homolog Member I-Induced Human Ovarian Cancer SKOV3 Cell Lines
    Zhu, Qiaoying
    Hu, Jianming
    Meng, Huijuan
    Shen, Yufei
    Zhou, Jinhua
    Zhu, Zhihong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (04) : 629 - 634
  • [39] The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)
    Inchakalody, Varghese P.
    Hydrose, Shereena P.
    Krishnankutty, Roopesh
    Merhi, Maysaloun
    Therachiyil, Lubna
    Nair, Varun Sasidharan
    Elashi, Asma A.
    Khan, Abdul Q.
    Taleb, Sara
    Raza, Afsheen
    Yoosuf, Zeenath Safira K. M.
    Fernandes, Queenie
    Al-Zaidan, Lobna
    Mestiri, Sarra
    Taib, Nassiba
    Bedhiafi, Takwa
    Moustafa, Dina
    Assami, Laila
    Maalej, Karama Makni
    Elkord, Eyad
    Uddin, Shahab
    Al Homsi, Ussama
    Dermime, Said
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 945
  • [40] Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway
    Aghaei, Mahmoud
    Panjehpour, Mojtaba
    Karami-Tehrani, Fatemeh
    Salami, Siamak
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1511 - 1523